|
COPENHAGEN, Denmark, Nov. 3, 2025 /PRNewswire/ -- Anthill , a leading content excellence and technology partner to the life sciences industry, has announced the launch of Anthill Cloud™ — an innovative platform that combines AI, modular content, and personalized engagement in one connected cloud ecosystem. Designed specifically for Pharma, MedTech, and Biotech, Anthill Cloud unifies content creation, governance, and omnichannel activation, accelerates time-to-market, and elevates HCP engagement.
Anthill Cloud brings together three powerful modules:
- Arcane™ – A generative AI tool that solves pharma's content discovery, reuse, and creation challenges. It reduces costs, removes complexity, and accelerates content production.
- Activator™ – A content authoring tool that speeds up production using pre-approved templates and modular content—fully integrated with Veeva PromoMats and Veeva MedComms.
- Amplify™ – A self-detailing tool that enables personalized, omnichannel engagement with HCPs 24/7, improving medical reps' performance and delivering measurable results.
"With Anthill Cloud, commercial and medical teams no longer need to choose between agility and compliance," said Rasmus Kalms, CPO of Anthill. "We've created a new content excellence ecosystem that redefines how pharma companies approach their omnichannel strategy. By combining AI, modular content, and automation, Anthill Cloud disrupts the entire process and makes healthcare communication faster, more innovative, and truly efficient."
Life science companies face growing content challenges: global product launches disconnected from local needs, overloaded digital libraries, overspending on unused digital assets, and lengthy approval processes with multiple regulatory checks.
Anthill Cloud addresses these challenges by offering:
- Scalable content creation and discovery, powered by compliant Generative AI.
- Fully automated and integrated modular content authoring for full discoverability.
- Highly personalized, interactive customer journeys tailored to HCPs' needs and preferences.
- A unified ecosystem that integrates with Veeva PromoMats, and any other DAM.
Anthill will showcase Anthill Cloud at the upcoming Veeva Commercial Summit Europe in Madrid. Attendees will have the opportunity to experience live demos and meet Anthill experts to discuss modernizing their content excellence journey.
Media Contact:
Tetiana Lushchuk
Head of Marketing, Anthill
tlu@anthill.technology
About Anthill
Anthill is a transformational content excellence company. We empower pharma companies to meet growing HCP expectations for high-quality, personalized experiences. By applying content excellence principles and technologies, Anthill enables pharma companies to increase the volume of content produced for omnichannel strategies, speed MLR approvals, and drive the rapid creation of omnichannel tactics.
COPENHAGEN, Denmark, Nov. 3, 2025 /PRNewswire/ -- Anthill , a leading content excellence and technology partner to the life sciences industry, has announced the launch of Anthill Cloud™ — an innovative platform that combines AI, modular content, and personalized engagement in one connected cloud ecosystem. Designed specifically for Pharma, MedTech, and Biotech, Anthill Cloud unifies content creation, governance, and omnichannel activation, accelerates time-to-market, and elevates HCP engagement.
Anthill Cloud brings together three powerful modules:
- Arcane™ – A generative AI tool that solves pharma's content discovery, reuse, and creation challenges. It reduces costs, removes complexity, and accelerates content production.
- Activator™ – A content authoring tool that speeds up production using pre-approved templates and modular content—fully integrated with Veeva PromoMats and Veeva MedComms.
- Amplify™ – A self-detailing tool that enables personalized, omnichannel engagement with HCPs 24/7, improving medical reps' performance and delivering measurable results.
"With Anthill Cloud, commercial and medical teams no longer need to choose between agility and compliance," said Rasmus Kalms, CPO of Anthill. "We've created a new content excellence ecosystem that redefines how pharma companies approach their omnichannel strategy. By combining AI, modular content, and automation, Anthill Cloud disrupts the entire process and makes healthcare communication faster, more innovative, and truly efficient."
Life science companies face growing content challenges: global product launches disconnected from local needs, overloaded digital libraries, overspending on unused digital assets, and lengthy approval processes with multiple regulatory checks.
Anthill Cloud addresses these challenges by offering:
- Scalable content creation and discovery, powered by compliant Generative AI.
- Fully automated and integrated modular content authoring for full discoverability.
- Highly personalized, interactive customer journeys tailored to HCPs' needs and preferences.
- A unified ecosystem that integrates with Veeva PromoMats, and any other DAM.
Anthill will showcase Anthill Cloud at the upcoming Veeva Commercial Summit Europe in Madrid. Attendees will have the opportunity to experience live demos and meet Anthill experts to discuss modernizing their content excellence journey.
Media Contact:
Tetiana Lushchuk
Head of Marketing, Anthill
tlu@anthill.technology
About Anthill
Anthill is a transformational content excellence company. We empower pharma companies to meet growing HCP expectations for high-quality, personalized experiences. By applying content excellence principles and technologies, Anthill enables pharma companies to increase the volume of content produced for omnichannel strategies, speed MLR approvals, and drive the rapid creation of omnichannel tactics.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Anthill Cloud: Transforming Pharma Marketing with AI, Modular Content, and Omnichannel Engagement
PUNE, India, April 2, 2026 /PRNewswire/ -- EKA Mobility, a leading electric vehicles and technology company, today announced a strong 5X year-on-year volume growth in FY 2025–26, with 1,143 units sold and 1,344 electric commercial vehicles produced. This milestone comes on the back of the company's comprehensive electric vehicle portfolio across segments. During the year, EKA entered the M&HCV truck segment, in addition to its existing bus and SCV portfolio. The company is a Champion OEM under the Auto PLI Scheme and has achieved certification across multiple platforms.
"FY 2025–26 is a defining year for EKA Mobility. We are not only scaling volumes but also expanding our manufacturing footprint by adding a new plant recently and increasing our planned annual capacity to 10,000 buses, 6,000 trucks and 24,000 SCVs. With the widest range of fully homologated, born-electric platforms from last-mile to long-haul, we are uniquely positioned as a full-stack EV company. Our growth across electric buses, small commercial vehicles, and now trucks validates both market demand and our execution capability.
India's transition to clean commercial mobility is accelerating, and EKA is at the forefront driving this shift at scale, with technology, innovation, and global ambition."
— Dr. Sudhir Mehta, Founder & Chairman, EKA Mobility
Strong Business Momentum Across Segments
- Electric Bus Leadership:
Secured wins under PM e-Bus Sewa and PM E-DRIVE; deployed vehicles across 15+ states including Maharashtra, Gujarat, Uttar Pradesh, Karnataka, and Delhi - SCV Breakout Year:
Strong uptake of 3S & 6S passenger vehicles and 3W cargo platforms, accelerating last-mile mobility adoption - Electric Trucks:
New Growth Engine: Entry into heavy-duty trucks contributing to growth and expanding presence in logistics electrification - Hydrogen Fuel Cell:
Deployed a 9-metre hydrogen fuel cell bus at Cochin International Airport with KPIT Technologies and BPCL; plans to deploy 15 more buses
Key Highlights:
Global Expansion:
- Commenced electric bus deployments in Africa
- Partnership with Kerchanshe Group for CKD assembly and distribution
- Agreement with NBFI Capital for manufacturing in Australia
Manufacturing Scale-Up:
- Two Pune facilities operational; Pithampur plant to be operational shortly
- Planned annual capacity: 10,000 buses, 6,000 trucks and 24,000 SCVs
Retail Network:
- Expanded dealership network; plans to add 120 dealerships in FY27
Order Book Visibility:
- 6,000+ confirmed e-buses to be delivered over the next two years
About EKA Mobility
EKA Mobility is a Pune-based electric vehicle and technology company focused on transforming India's commercial mobility landscape. With a portfolio spanning electric buses, electric trucks, and small commercial vehicles, EKA combines electric vehicle manufacturing with proprietary AI-powered fleet technology to deliver end-to-end mobility solutions.
EKA Mobility is backed by Mitsui & Co., Ltd. (Japan), VDL Groep (Netherlands), Pinnacle Industries Limited, Enam Holdings and the NIIF India-Japan Fund as equity and strategic partners and has expanded its footprint to markets in East Africa, South Africa, and Australia.
To know more about the company, kindly visit: https://ekamobility.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
EKA Mobility Achieves 5x Volume Growth
